aml

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

Recruiting
  • AML
  • MDS
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

Active, not recruiting
  • AML
  • Flotetuzumab dose escalation
  • +2 more
  • Duarte, California
  • +42 more
Mar 7, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

AML, MDS Trial in United States (APVO436)

Recruiting
  • AML
  • MDS
  • APVO436
  • San Francisco, California
  • +11 more
Feb 8, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome Trial in Georgia, United States (AC220)

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +4 more
Apr 23, 2020

Leukemia, AML, MDS Trial in Houston (Azacitidine)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

AML, MDS, CMML Trial in United States (E6201)

Terminated
  • AML
  • +2 more
  • Denver, Colorado
  • +3 more
Mar 7, 2019

AML, Acute Myeloid Leukemia, Myelodysplastic Disorders Trial in Houston (Idarubicin, Sorafenib, Ara-C)

Completed
  • AML
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jul 23, 2018

Leukemia, Acute Myeloid Leukemia, AML Trial in Houston (Cytarabine, Idarubicin)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 23, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS Trial in Worldwide (BYL719, MEK162)

Completed
  • Advanced and Selected Solid Tumors
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2017

AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)

Completed
  • AML
  • +4 more
  • TG02 citrate
  • +2 more
  • Denver, Colorado
  • +8 more
May 5, 2016

Leukemia, AML, MDS Trial in Houston (Cytarabine, Fludarabine)

Completed
  • Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 17, 2016

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013

AML Trial in Canada, United States (Obatoclax)

Completed
  • AML
  • Chicago, Illinois
  • +12 more
Aug 16, 2013

Acute Myeloid Leukemia, AML Trial in Canada, Netherlands, United States (Tosedostat)

Completed
  • Acute Myeloid Leukemia
  • AML
  • Los Angeles, California
  • +20 more
Jun 27, 2012